125 related articles for article (PubMed ID: 18296650)
1. Identification of flotillin-2, a major protein on lipid rafts, as a novel target of p53 family members.
Sasaki Y; Oshima Y; Koyama R; Maruyama R; Akashi H; Mita H; Toyota M; Shinomura Y; Imai K; Tokino T
Mol Cancer Res; 2008 Mar; 6(3):395-406. PubMed ID: 18296650
[TBL] [Abstract][Full Text] [Related]
2. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.
Boldrup L; Coates PJ; Gu X; Nylander K
J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121
[TBL] [Abstract][Full Text] [Related]
3. Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73.
Petitjean A; Ruptier C; Tribollet V; Hautefeuille A; Chardon F; Cavard C; Puisieux A; Hainaut P; Caron de Fromentel C
Carcinogenesis; 2008 Feb; 29(2):273-81. PubMed ID: 18048390
[TBL] [Abstract][Full Text] [Related]
4. Differential recognition of response elements determines target gene specificity for p53 and p63.
Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
[TBL] [Abstract][Full Text] [Related]
5. A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells.
Yu J; Baron V; Mercola D; Mustelin T; Adamson ED
Cell Death Differ; 2007 Mar; 14(3):436-46. PubMed ID: 16990849
[TBL] [Abstract][Full Text] [Related]
6. Targeted repression of bone morphogenetic protein 7, a novel target of the p53 family, triggers proliferative defect in p53-deficient breast cancer cells.
Yan W; Chen X
Cancer Res; 2007 Oct; 67(19):9117-24. PubMed ID: 17909016
[TBL] [Abstract][Full Text] [Related]
7. Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1.
Britschgi C; Rizzi M; Grob TJ; Tschan MP; Hügli B; Reddy VA; Andres AC; Torbett BE; Tobler A; Fey MF
Oncogene; 2006 Mar; 25(14):2030-9. PubMed ID: 16301995
[TBL] [Abstract][Full Text] [Related]
8. p53 family members regulate the expression of the apolipoprotein D gene.
Sasaki Y; Negishi H; Koyama R; Anbo N; Ohori K; Idogawa M; Mita H; Toyota M; Imai K; Shinomura Y; Tokino T
J Biol Chem; 2009 Jan; 284(2):872-83. PubMed ID: 19001418
[TBL] [Abstract][Full Text] [Related]
9. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia induces p53-dependent transactivation and Fas/CD95-dependent apoptosis.
Liu T; Laurell C; Selivanova G; Lundeberg J; Nilsson P; Wiman KG
Cell Death Differ; 2007 Mar; 14(3):411-21. PubMed ID: 16917513
[TBL] [Abstract][Full Text] [Related]
11. Regulation of protein Citrullination through p53/PADI4 network in DNA damage response.
Tanikawa C; Ueda K; Nakagawa H; Yoshida N; Nakamura Y; Matsuda K
Cancer Res; 2009 Nov; 69(22):8761-9. PubMed ID: 19843866
[TBL] [Abstract][Full Text] [Related]
12. Co-activator SRC-1 is dispensable for transcriptional control by STAT3.
Cvijic H; Bauer K; Löffler D; Pfeifer G; Blumert C; Kretzschmar AK; Henze C; Brocke-Heidrich K; Horn F
Biochem J; 2009 Apr; 420(1):123-32. PubMed ID: 19203349
[TBL] [Abstract][Full Text] [Related]
13. DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter.
Liu H; Hew HC; Lu ZG; Yamaguchi T; Miki Y; Yoshida K
Biochem J; 2009 Aug; 422(3):543-51. PubMed ID: 19558368
[TBL] [Abstract][Full Text] [Related]
14. The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.
Ou YH; Chung PH; Hsu FF; Sun TP; Chang WY; Shieh SY
EMBO J; 2007 Sep; 26(17):3968-80. PubMed ID: 17690688
[TBL] [Abstract][Full Text] [Related]
15. Dissecting the molecular function of reggie/flotillin proteins.
Babuke T; Tikkanen R
Eur J Cell Biol; 2007 Sep; 86(9):525-32. PubMed ID: 17482313
[TBL] [Abstract][Full Text] [Related]
16. Ablation of Stat3 by siRNA alters gene expression profiles in JEG-3 cells: a systems biology approach.
Jiang K; Krous LC; Knowlton N; Chen Y; Frank MB; Cadwell C; Centola M; Jarvis JN
Placenta; 2009 Sep; 30(9):806-15. PubMed ID: 19616846
[TBL] [Abstract][Full Text] [Related]
17. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
[TBL] [Abstract][Full Text] [Related]
18. The expression of phosphatidic acid phosphatase 2a, which hydrolyzes lipids to generate diacylglycerol, is regulated by p73, a member of the p53 family.
Ishida T; Iwai A; Hijikata M; Shimotohno K
Biochem Biophys Res Commun; 2007 Feb; 353(1):74-9. PubMed ID: 17169329
[TBL] [Abstract][Full Text] [Related]
19. hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes.
Tanaka T; Ohkubo S; Tatsuno I; Prives C
Cell; 2007 Aug; 130(4):638-50. PubMed ID: 17719542
[TBL] [Abstract][Full Text] [Related]
20. Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation.
Maruyama R; Aoki F; Toyota M; Sasaki Y; Akashi H; Mita H; Suzuki H; Akino K; Ohe-Toyota M; Maruyama Y; Tatsumi H; Imai K; Shinomura Y; Tokino T
Cancer Res; 2006 May; 66(9):4574-83. PubMed ID: 16651407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]